GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Xinhua Pharmaceutical Co Ltd (HKSE:00719) » Definitions » 5-Year Yield-on-Cost %

Shandong Xinhua Pharmaceutical Co (HKSE:00719) 5-Year Yield-on-Cost % : 15.33 (As of May. 21, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Shandong Xinhua Pharmaceutical Co 5-Year Yield-on-Cost %?

Shandong Xinhua Pharmaceutical Co's yield on cost for the quarter that ended in Mar. 2024 was 15.33.


The historical rank and industry rank for Shandong Xinhua Pharmaceutical Co's 5-Year Yield-on-Cost % or its related term are showing as below:

HKSE:00719' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.44   Med: 2.33   Max: 15.37
Current: 15.33


During the past 13 years, Shandong Xinhua Pharmaceutical Co's highest Yield on Cost was 15.37. The lowest was 0.44. And the median was 2.33.


HKSE:00719's 5-Year Yield-on-Cost % is ranked better than
77.64% of 501 companies
in the Drug Manufacturers industry
Industry Median: 2.09 vs HKSE:00719: 15.33

Competitive Comparison of Shandong Xinhua Pharmaceutical Co's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Xinhua Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Xinhua Pharmaceutical Co's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Xinhua Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Shandong Xinhua Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.



Shandong Xinhua Pharmaceutical Co 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Shandong Xinhua Pharmaceutical Co is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Shandong Xinhua Pharmaceutical Co  (HKSE:00719) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Shandong Xinhua Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Shandong Xinhua Pharmaceutical Co's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Xinhua Pharmaceutical Co (HKSE:00719) Business Description

Traded in Other Exchanges
Address
No. 1 Lutai Avenue, Hi-tech Industry Development Zone, Zibo City, Shandong, CHN, 255086
Shandong Xinhua Pharmaceutical Co Ltd is a pharmaceutical products manufacturer based in China. It operates the business through the following segments: Chemical bulk drugs, Preparations, Chemical intermediates, and other products. The company provides chemical bulk drug products, including metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, and L-dopa, it also dispenses formulation products such as compound liquorice tablets and nimodipine tablets. Its products address disorders related to the central nervous system and the cerebrovascular system with the help of antipyretics and analgesics.

Shandong Xinhua Pharmaceutical Co (HKSE:00719) Headlines

No Headlines